GODAVARI.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
GODAVARI.BOGodavari Drugs Limited	$109.95	-1.77%	$1.1B	—
ASPIRA.BOAspira Pathlab & Diagnostics Limited	$109.53	+4.99%	$1.1B	—
BIOFILCHEM.BOBiofil Chemicals and Pharmaceuticals Limited	$32.99	-0.33%	$538M	—
BIOFILCHEM.NSBiofil Chemicals and Pharmaceuticals Limited	$32.86	-0.81%	$535M	—
CHOKSI.BOChoksi Asia Limited	$229.95	-2.23%	$1.3B	—
CONCORD.BOConcord Drugs Limited	$77.02	-2.88%	$855M	—
MAKERSL.BOMakers Laboratories Limited	$184.95	+2.78%	$1.1B	—

Source: Financial Modeling Prep · peers by sector/industry

Godavari Drugs Limited

Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Ciprofloxacin Hydrochloride, Enrofloxacin, Centrizine Hydrochloride, Ethambutol Hydrochloride, A D Lactone, and Benzhyryl Piperazine. The company was founded on December 2, 1987 and is headquartered in Secunderabad, India.

www.godavaridrugs.com

Employees: 112
IPO / List date: Dec 30, 2024
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds GODAVARI.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in GODAVARI.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded GODAVARI.BO yet.